Search results
Özlem Türeci (Turkish pronunciation: [ˈœzlem ˈtyredʒi]; born 6 March 1967) is a German physician, scientist and entrepreneur. In 2008, she co-founded the biotechnology company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19.
Özlem Türeci is a physician, immunologist and cancer researcher who cofounded BioNTech with her husband Uğur Şahin. She leads the clinical development of the company's mRNA-based vaccine against COVID-19 and other immunotherapies.
Nov 10, 2020 · The German company BioNTech, founded by two scientists, has teamed up with Pfizer on a vaccine that was found to be more than 90 percent effective. Dr. Ugur Sahin, left, and Dr. Özlem Türeci ...
Dec 16, 2020 · The mere fact that a safe and effective inoculation is available less than a year after the genetic sequence for a new, pneumonia-like pathogen was released puts the achievement by Dr Sahin and Dr ...
Prof. Özlem Türeci, M.D., Co-Founder and Chief Medical Officer of BioNTech, is a physician, immunologist, and cancer researcher with translational and clinical experience. Türeci has helped lead the discovery of cancer antigens, the development of mRNA-based individualized and off-the-shelf vaccine candidates and other types of ...
As COVID-19 spread, BioNTech cofounders Uğur Şahin and Özlem Türeci had one goal: to make a safe, effective vaccine faster than ever before.
The world-renowned immunologist, cancer researcher, and entrepreneur Özlem Türeci has accepted the professorship of Personalized Immunotherapy at the Mainz University Medical Center and the Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, which was founded in 2019.
